Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$15.35
-1.7%
$13.64
$12.00
$18.68
$95.17M117,288 shs23,234 shs
Nephros Inc. stock logo
NEPH
Nephros
$3.99
-1.1%
$2.92
$1.36
$5.00
$42.24M1.0917,775 shs12,502 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.25
+0.9%
$2.45
$1.99
$3.80
$68.96M0.5966,082 shs128,319 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.69
+1.0%
$4.70
$4.01
$9.33
$76.87M1.29191,281 shs31,255 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
+4.41%+10.39%+8.47%+15.36%-3.22%
Nephros Inc. stock logo
NEPH
Nephros
-1.47%-3.13%+53.23%+98.52%+91.00%
InspireMD, Inc. stock logo
NSPR
InspireMD
-1.76%-9.72%-11.86%-14.56%-8.61%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-2.11%-1.49%-2.52%-7.75%-6.92%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
1.7574 of 5 stars
0.03.00.00.03.30.81.9
Nephros Inc. stock logo
NEPH
Nephros
2.3835 of 5 stars
3.53.00.00.03.30.80.0
InspireMD, Inc. stock logo
NSPR
InspireMD
3.0303 of 5 stars
3.54.00.00.01.52.50.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.0196 of 5 stars
3.63.00.00.02.50.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
3.00
Buy$5.0025.47% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5099.91% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67149.02% Upside

Current Analyst Ratings Breakdown

Latest NEPH, FONR, NSPR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.93$3.16 per share4.86$24.78 per share0.62
Nephros Inc. stock logo
NEPH
Nephros
$14.16M2.98$0.02 per share204.39$0.81 per share4.92
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M9.81N/AN/A$1.83 per share1.23
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.84$0.43 per share10.97$3.41 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.28N/A8.19%5.31%3.97%N/A
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.0756.94N/A5.16%9.43%7.20%8/6/2025 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1046.7620.37N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest NEPH, FONR, NSPR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/15/2025Q1 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.92
4.64
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
InspireMD, Inc. stock logo
NSPR
InspireMD
29.72%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$15.35 -0.27 (-1.73%)
As of 03:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Nephros stock logo

Nephros NASDAQ:NEPH

$3.98 -0.05 (-1.12%)
As of 03:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.25 +0.02 (+0.94%)
As of 03:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.68 +0.05 (+0.97%)
As of 03:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.